LONDON: British healthcare start-up Medopad is planning US expansion with a new office in New York, the company CEO has said.
According to the company’s CEO Dan Vahdat, the Medopad is to set up shop at Johnson & Johnson’s New York offices.
Medopad has experienced significant growth in UK, and US market expansion seems a natural move.
The company’s mobile apps remotely track patients’ wellbeing.
The apps can also analyse data from other devices such as the Apple Watch.
